Evidence map›Paper›PMID 36459593›Full record

ArticleJournal of chemical theory and computation2022

Protein-Ligand Binding Free-Energy Calculations with ARROW─A Purely First-Principles Parameterized Polarizable Force Field.

Grzegorz Nawrocki, Igor Leontyev, Serzhan Sakipov, Mikhail Darkhovskiy, Igor Kurnikov, Leonid Pereyaslavets, Ganesh Kamath, Ekaterina Voronina, Oleg Butin, Alexey Illarionov and 11 more

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Grzegorz NawrockiInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.ORCID 0000-0002-7115-5857
Igor LeontyevInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Serzhan SakipovInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Mikhail DarkhovskiyInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Igor KurnikovInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Leonid PereyaslavetsInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Ganesh KamathInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Ekaterina VoroninaInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Oleg ButinInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Alexey IllarionovInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Michael OlevanovFaculty of Physics, Lomonosov Moscow State University, Moscow 119991, Russia.
Alexander KostikovInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Ilya IvahnenkoInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Dhilon S PatelDepartment of Chemistry, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States.
Subramanian K R S SankaranarayananCenter for Nanoscale Materials, Argonne National Lab, Lemont, Illinois 60439, United States.
Maria G KurnikovaDepartment of Chemistry, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States.ORCID 0000-0002-8010-8374
Christopher LockInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.ORCID 0000-0002-4087-5894
Gavin E CrooksInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.
Michael LevittDepartment of Structural Biology, Stanford University School of Medicine, Stanford, California 94305, United States.
Roger D KornbergDepartment of Structural Biology, Stanford University School of Medicine, Stanford, California 94305, United States.
Boris FainInterX Inc., 805 Allston Way, Berkeley California, 94710, United States.

Funding

Emergent Properties of Complex Systems: From Atoms to Macromolecules; from Humans to SocietiesR35GM122543 · NIGMS · STANFORD UNIVERSITY · PI MICHAEL LEVITT · 2017 to 2026
$5.1M
NIGMS NIH HHS R35 GM122543
6 · The paper itself

Abstract

Protein-ligand binding free-energy calculations using molecular dynamics (MD) simulations have emerged as a powerful tool for in silico drug design. Here, we present results obtained with the ARROW force field (FF)─a multipolar polarizable and physics-based model with all parameters fitted entirely to high-level ab initio quantum mechanical (QM) calculations. ARROW has already proven its ability to determine solvation free energy of arbitrary neutral compounds with unprecedented accuracy. The ARROW FF parameterization is now extended to include coverage of all amino acids including charged groups, allowing molecular simulations of a series of protein-ligand systems and prediction of their relative binding free energies. We ensure adequate sampling by applying a novel technique that is based on coupling the Hamiltonian Replica exchange (HREX) with a conformation reservoir generated via potential softening and nonequilibrium MD. ARROW provides predictions with near chemical accuracy (mean absolute error of ∼0.5 kcal/mol) for two of the three protein systems studied here (MCL1 and Thrombin). The third protein system (CDK2) reveals the difficulty in accurately describing dimer interaction energies involving polar and charged species. Overall, for all of the three protein systems studied here, ARROW FF predicts relative binding free energies of ligands with a similar accuracy level as leading nonpolarizable force fields.

Indexed as

Molecular Dynamics SimulationProteinsEntropyLigandsMolecular ConformationProtein BindingThermodynamicsLigandsProteins

Identifiers

PMID36459593
PMCPMC9753910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.